Skin Cancer and Melanoma Market Research

Goals

To determine insights on early detection of skin cancer and melanoma as well as providing insights on the Chinese skin cancer market. Research will be used to guide direction of a company and help raise funding.

Early Findings

EARLY DETECTION

RISK FACTORS

COST

  • Treating skin cancer in the US costs an estimated $8.1 billion annually.
  • The annual cost of treating non-melanoma skin cancer stands at $4.8 billion.
  • The annual cost of treating melanoma skin cancer is estimated to be $3.3 billion.

Proposed next steps:

You need to be the project owner to select a next step.
As the initial hour of research provided insights on early detection, risk factors and cost, we recommend continuing research to provide insights on the number of incurable cases due to late detection as well as available solutions for early detection and public awareness.
Alternatively, we can also continue research to try to determine the percentage of early detection made by dermatologists and percentage of late detection due to failure to secure appointments with dermatologists. We can also research the free screening for skin cancer initiative by the US government and determine if it is covered by insurance.
Lastly, we can research the skin cancer market in China including growth, trends, awareness and other insights.